Aarhus University Seal / Aarhus Universitets segl

Mette Bjerre

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Standard

Soluble Receptor for Advanced Glycation End Product : A Biomarker for Acute Coronary Syndrome. / Jensen, Louise J N; Flyvbjerg, Allan; Bjerre, Mette.

I: BioMed Research International, Bind 2015, 815942, 2015.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Jensen, Louise J N ; Flyvbjerg, Allan ; Bjerre, Mette. / Soluble Receptor for Advanced Glycation End Product : A Biomarker for Acute Coronary Syndrome. I: BioMed Research International. 2015 ; Bind 2015.

Bibtex

@article{f167d9df9e7944afaa59ec8e09370cc7,
title = "Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome",
abstract = "The receptor of advanced glycation end products (RAGE) and its ligands are linked to the pathogenesis of coronary artery disease (CAD), and circulating soluble receptor of advanced glycation end products (sRAGE), reflecting the RAGE activity, is suggested as a potential biomarker. Elevated sRAGE levels are reported in relation to acute ischemia and this review focuses on the role of sRAGE as a biomarker for the acute coronary syndrome (ACS). The current studies demonstrated that sRAGE levels are elevated in relation to ACS, however during a very narrow time period, indicating that the time of sampling needs attention. Interestingly, activation of RAGE may influence the pathogenesis and reflection in sRAGE levels in acute and stable CAD differently.",
author = "Jensen, {Louise J N} and Allan Flyvbjerg and Mette Bjerre",
year = "2015",
doi = "10.1155/2015/815942",
language = "English",
volume = "2015",
journal = "Journal of Biomedicine and Biotechnology",
issn = "1110-7243",
publisher = "Hindawi Publishing Corporation",

}

RIS

TY - JOUR

T1 - Soluble Receptor for Advanced Glycation End Product

T2 - A Biomarker for Acute Coronary Syndrome

AU - Jensen, Louise J N

AU - Flyvbjerg, Allan

AU - Bjerre, Mette

PY - 2015

Y1 - 2015

N2 - The receptor of advanced glycation end products (RAGE) and its ligands are linked to the pathogenesis of coronary artery disease (CAD), and circulating soluble receptor of advanced glycation end products (sRAGE), reflecting the RAGE activity, is suggested as a potential biomarker. Elevated sRAGE levels are reported in relation to acute ischemia and this review focuses on the role of sRAGE as a biomarker for the acute coronary syndrome (ACS). The current studies demonstrated that sRAGE levels are elevated in relation to ACS, however during a very narrow time period, indicating that the time of sampling needs attention. Interestingly, activation of RAGE may influence the pathogenesis and reflection in sRAGE levels in acute and stable CAD differently.

AB - The receptor of advanced glycation end products (RAGE) and its ligands are linked to the pathogenesis of coronary artery disease (CAD), and circulating soluble receptor of advanced glycation end products (sRAGE), reflecting the RAGE activity, is suggested as a potential biomarker. Elevated sRAGE levels are reported in relation to acute ischemia and this review focuses on the role of sRAGE as a biomarker for the acute coronary syndrome (ACS). The current studies demonstrated that sRAGE levels are elevated in relation to ACS, however during a very narrow time period, indicating that the time of sampling needs attention. Interestingly, activation of RAGE may influence the pathogenesis and reflection in sRAGE levels in acute and stable CAD differently.

U2 - 10.1155/2015/815942

DO - 10.1155/2015/815942

M3 - Review

C2 - 26491690

VL - 2015

JO - Journal of Biomedicine and Biotechnology

JF - Journal of Biomedicine and Biotechnology

SN - 1110-7243

M1 - 815942

ER -